Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial.
Verheyen N, Grübler MR, Meinitzer A, Trummer C, Schwetz V, Amrein K, Dimai HP, März W, Catena C, von Lewinski D, Voelkl J, Alesutan I, Fahrleitner-Pammer A, Brussee H, Pilz S, Tomaschitz A. Verheyen N, et al. Among authors: alesutan i. Bone. 2017 Dec;105:212-217. doi: 10.1016/j.bone.2017.08.030. Epub 2017 Sep 14. Bone. 2017. PMID: 28918310 Clinical Trial.
Vascular calcification--is aldosterone a culprit?
Lang F, Ritz E, Voelkl J, Alesutan I. Lang F, et al. Among authors: alesutan i. Nephrol Dial Transplant. 2013 May;28(5):1080-4. doi: 10.1093/ndt/gft041. Epub 2013 Mar 8. Nephrol Dial Transplant. 2013. PMID: 23476041 Review.
Homoarginine in the renal and cardiovascular systems.
Pilz S, Meinitzer A, Gaksch M, Grübler M, Verheyen N, Drechsler C, Hartaigh BÓ, Lang F, Alesutan I, Voelkl J, März W, Tomaschitz A. Pilz S, et al. Among authors: alesutan i. Amino Acids. 2015 Sep;47(9):1703-13. doi: 10.1007/s00726-015-1993-2. Epub 2015 May 1. Amino Acids. 2015. PMID: 25929587 Review.
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.
Tomaschitz A, Verheyen N, Meinitzer A, Pieske B, Belyavskiy E, Brussee H, Haas J, März W, Pieske-Kraigher E, Verheyen S, Ofner-Ziegenfuss L, Hartaigh BÓ, Schwetz V, Aberer F, Grübler M, Lang F, Alesutan I, Voelkl J, Gaksch M, Horina JH, Dimai HP, Rus-Machan J, Stiegler C, Ritz E, Fahrleitner-Pammer A, Pilz S. Tomaschitz A, et al. Among authors: alesutan i. J Hypertens. 2016 Jul;34(7):1347-56. doi: 10.1097/HJH.0000000000000927. J Hypertens. 2016. PMID: 27065001 Clinical Trial.
113 results